Researchers develop method to evaluate variations identified in breast cancer...
PharmaBiz: 1 views since Wednesday, July 9, 2008 at 04:47 AM
Using mouse embryonic stem cells, researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, have developed a new method to evaluate which mutations, or changes, in a gene known to increase breast cancer susceptibility, may lead to cancer.

Published in: Institutes